Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
1 participants
INTERVENTIONAL
2011-02-28
2011-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A total of 30 women will participate in the study at William Beaumont Hospital, Royal Oak.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
5% Lidocaine Ointment in the Treatment of Vulvar Vestibulitis
NCT00450242
The Effect of Lubricating Gel on Patient Comfort During Speculum Insertion.
NCT01289665
Safety and Efficacy of Two Vaginal Products Versus Placebo in Patients With Vaginal Discomfort
NCT00590590
Effectiveness and Safety of a Water-based and a Silicone-based Personal Lubricants With Sensory Action
NCT05644444
Evaluation of Gynecological Acceptability of a Health Care Product
NCT04247022
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Women will be randomized into 2 groups--a treatment group or placebo group for the 1 month study.
* At the end of the study, those in the placebo group may choose to participate in a 1 month follow-up evaluation using emu oil.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Emu Oil
Emu Oil
Subjects will apply a specified amount of emu oil daily to area.
inert oil
Inert oil
A specified amount of inert oil will be applied daily to area.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Emu Oil
Subjects will apply a specified amount of emu oil daily to area.
Inert oil
A specified amount of inert oil will be applied daily to area.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 or older.
* Capable of giving informed consent.
* Capable and willing to follow all study procedures.
Exclusion Criteria
* Vaginitis (may be treated, then tested later).
* Vulvar disease (other than vulvodynia)-lichen planus, lichen sclerosis, neoplasia, tissue damage due to radiation.
* The subject is deemed unsuitable for enrollment by the investigators based on their history or physical examination.
* Neuropathy.
* Currently in pelvic floor physical therapy.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
William Beaumont Hospitals
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Donna J Carrico, WHNP, MS
Role: PRINCIPAL_INVESTIGATOR
William Beaumont Hospitals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beaumont Women's Urology Center
Royal Oak, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.